$MDAI
Spectral AI, Inc. Stock $mdai

$mdai Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024067651 Filed on August 12, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$8.173M	$7.478M	$5.287M
YoY Change	137.59%
Cost Of Revenue	$4.506M	$4.164M	$2.851M
YoY Change	128.96%	69.27%
Gross Profit	$3.667M	$3.314M	$2.436M
YoY Change	149.12%	85.04%
Gross Profit Margin	44.87%	44.32%	46.08%
Selling, General & Admin	$4.553M	$5.756M	$5.365M
YoY Change	-19.24%	290.07%	1687.62%
% of Gross Profit	124.16%	173.69%	220.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.000K	$2.000K	$2.000K
YoY Change	-71.43%
% of Gross Profit	0.05%	0.06%	0.08%
Operating Expenses	$4.553M	$5.756M	$5.365M
YoY Change	-19.24%	290.07%	1687.62%
Operating Profit	-$886.0K	-$2.442M	-$2.929M
YoY Change	-78.73%	65.49%
Interest Expense	-$17.00K	-$15.00K	$31.00K
YoY Change	-194.44%	-125.6%	-98.45%
% of Operating Profit
Other Income/Expense, Net	-$581.0K	-$353.0K	-$669.0K
YoY Change	-91.08%	-189.55%
Pretax Income	-$1.467M	-$2.795M	-$3.567M
YoY Change	-86.27%	173.26%	-309.44%
Income Tax	$37.00K	$69.00K	-$21.00K
% Of Pretax Income
Net Earnings	-$1.504M	-$2.864M	-$3.546M
YoY Change	-85.85%	177.18%	-364.51%
Net Earnings / Revenue	-18.4%	-38.3%	-67.07%
Basic Earnings Per Share	-$0.08	-$0.16
Diluted Earnings Per Share	-$0.08	-$0.16	-$0.47
COMMON SHARES
Basic Shares Outstanding	17.61M shares	17.48M shares	16.25M shares
Diluted Shares Outstanding	17.86M shares	17.60M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.702M	$41.88M	$4.790M
YoY Change	-49.62%	10138.12%	510.16%
Cash & Equivalents	$3.702M	$6.877M	$4.790M
Short-Term Investments		$35.00M
Other Short-Term Assets	$1.011M	$973.0K	$2.536M
YoY Change	70.2%	473.64%	1551.26%
Inventory	$443.0K	$267.0K	$230.0K
Prepaid Expenses	$1.506M	$1.249M	$1.452M
Receivables	$2.834M	$2.295M	$2.346M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.496M	$11.66M	$9.902M
YoY Change	-16.38%	1915.22%	954.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.000K	$7.000K	$790.0K
YoY Change	-64.29%		3661.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.106M	$2.236M	$790.0K
YoY Change	116.0%	-52.68%	-82.92%
TOTAL ASSETS
Total Short-Term Assets	$9.496M	$11.66M	$9.902M
Total Long-Term Assets	$2.106M	$2.236M	$790.0K
Total Assets	$11.60M	$13.90M	$10.69M
YoY Change	-5.91%	162.0%	92.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.797M	$2.403M	$2.683M
YoY Change	-14.6%		-2.75%
Accrued Expenses	$3.253M	$2.733M	$3.483M
YoY Change	-18.33%	-45.29%	3.9%
Deferred Revenue	$731.0K	$1.315M	$2.311M
YoY Change
Short-Term Debt	$4.974M	$8.001M	$436.0K
YoY Change	687.03%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.07M	$16.13M	$12.40M
YoY Change	22.74%	205.17%	242.22%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.870M	$2.036M	$0.00
YoY Change	1158.77%	-78.89%	-100.0%
Total Long-Term Liabilities	$2.870M	$2.036M	$0.00
YoY Change	1158.77%	-78.89%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.07M	$16.13M	$12.40M
Total Long-Term Liabilities	$2.870M	$2.036M	$0.00
Total Liabilities	$15.94M	$18.16M	$12.40M
YoY Change	46.56%	21.67%	-3.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$40.40M	-$38.90M	-$32.79M
YoY Change	38.16%	168.68%	171.05%
Common Stock	$2.000K	$2.000K	$2.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.336M	-$4.265M	-$1.709M
YoY Change
Total Liabilities & Shareholders Equity	$11.60M	$13.90M	$10.69M
YoY Change	-5.91%	162.0%	92.14%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	-$1.504M	-$2.864M	-$3.546M
YoY Change	-85.85%	177.18%	-364.51%
Depreciation, Depletion And Amortization	$2.000K	$2.000K	$2.000K
YoY Change	-71.43%
Cash From Operating Activities	-$1.626M	-$5.362M	-$2.375M
YoY Change	-84.49%	3937.35%	463.61%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.564M	2.082M	-195.0K
YoY Change	-138.72%		-99.92%
NET CHANGE
Cash From Operating Activities	-1.626M	-5.362M	-2.375M
Cash From Investing Activities
Cash From Financing Activities	-1.564M	2.082M	-195.0K
Net Change In Cash	-3.190M	-3.280M	-2.570M
YoY Change	-50.51%	2369.69%	-1061.83%
FREE CASH FLOW
Cash From Operating Activities	-$1.626M	-$5.362M	-$2.375M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13200515	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2515 McKinney Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1000
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75201
	dei	City Area Code CityAreaCode	(972)
	dei	Local Phone Number LocalPhoneNumber	499-4934
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17606367	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6877000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4790000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2295000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2346000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	267000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	230000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	283000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1249000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1452000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	973000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	801000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	11661000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9902000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2229000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	778000	usd
CY2024Q2	us-gaap	Assets Assets	13897000	usd
CY2023Q4	us-gaap	Assets Assets	10692000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2403000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2683000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2733000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4300000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1315000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2311000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	224000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	853000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	436000	usd
CY2024Q2	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7001000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1450000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1818000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16126000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12401000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2036000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	18162000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12401000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17606367	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17606367	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16294935	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16294935	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34580000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31065000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38857000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32788000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4265000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1709000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13897000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10692000	usd
CY2024Q2	us-gaap	Revenues Revenues	7478000	usd
CY2023Q2	us-gaap	Revenues Revenues	4251000	usd
	us-gaap	Revenues Revenues	13804000	usd
	us-gaap	Revenues Revenues	9329000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	4164000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2460000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	7545000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5357000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	3314000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1791000	usd
	us-gaap	Gross Profit GrossProfit	6259000	usd
	us-gaap	Gross Profit GrossProfit	3972000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5756000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4782000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10844000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9861000	usd
CY2024Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5756000	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4782000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10844000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9861000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2442000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2991000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4585000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5889000	usd
CY2024Q2	us-gaap	Investment Income Net InvestmentIncomeNet	-6000	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	42000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	8000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	86000	usd
CY2024Q2	mdai	Borrowing Related Costs BorrowingRelatedCosts	699000	usd
	mdai	Borrowing Related Costs BorrowingRelatedCosts	975000	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-348000	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	81000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-368000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	65000	usd
CY2024Q2	mdai	Fair Value Adjustment Of Notes Payable FairValueAdjustmentOfNotesPayable	167000	usd
	mdai	Fair Value Adjustment Of Notes Payable FairValueAdjustmentOfNotesPayable	101000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	13000	usd
CY2024Q2	mdai	Transaction Costs Incurred In Connection With Warrant Liabilities TransactionCostsIncurredInConnectionWithWarrantLiabilities	-180000	usd
	mdai	Transaction Costs Incurred In Connection With Warrant Liabilities TransactionCostsIncurredInConnectionWithWarrantLiabilities	668000	usd
	mdai	Transaction Costs Incurred In Connection With Warrant Liabilities TransactionCostsIncurredInConnectionWithWarrantLiabilities	738000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-353000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-39000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1393000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-704000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2795000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3030000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5978000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6593000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	86000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2864000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3070000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6069000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6679000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17598357	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13210320	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17079328	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13200515	shares
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	2000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-2000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	3000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2864000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3068000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6071000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6676000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1709000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	283000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2605000	usd
CY2024Q1	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-2000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3205000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2028000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	402000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	225000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2864000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4265000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11996000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	300000	usd
CY2023Q1	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3609000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8688000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	396000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2023Q2	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	2000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3070000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6022000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6069000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6679000	usd
	us-gaap	Depreciation Depreciation	5000	usd
	us-gaap	Depreciation Depreciation	5000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	685000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	696000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-320000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-350000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-368000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	65000	usd
	mdai	Change In Fair Values Of Notes Payable ChangeInFairValuesOfNotesPayable	-101000	usd
	mdai	Costs From Issuance Of Common Stock CostsFromIssuanceOfCommonStock	372000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-51000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-774000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	37000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-527000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-203000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	11000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	172000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	322000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-206000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-752000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1567000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-405000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-996000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	509000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-364000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-284000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8042000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5527000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2667000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	9200000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1000000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	306000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2736000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	175000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10131000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-481000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2087000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6008000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4790000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14174000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6877000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8166000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1771000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	483000	usd
	mdai	Unpaid Deferred Offering Costs UnpaidDeferredOfferingCosts	818000	usd
	mdai	Broker Receivable For Stock Option Exercises BrokerReceivableForStockOptionExercises	6000	usd
CY2023Q3	mdai	Common Stock Exchange Ratio Price CommonStockExchangeRatioPrice	10.31
CY2023Q3	mdai	Contract Value ContractValue	150000000	usd
CY2024Q2	mdai	Contract Inital Award Value ContractInitalAwardValue	54900000	usd
CY2023Q2	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	4000000	usd
CY2024Q1	us-gaap	Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation	1000000	usd
CY2024Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38900000	usd
CY2024Q2	us-gaap	Other Notes Payable OtherNotesPayable	8000000	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	400000	usd
CY2023Q4	mdai	Aggregate Gross Purchase Price AggregateGrossPurchasePrice	10000000	usd
CY2024Q1	us-gaap	Program Rights Obligations ProgramRightsObligations	30000000	usd
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	3000000	usd
	mdai	Additional Development Amount AdditionalDevelopmentAmount	500000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	35000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company’s balance sheets and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, revenue recognition, warrant liabilities, the fair value of short term notes payable, fair value of the B. Riley and Yorkville derivative instruments, stock-based compensation expense, stock issued for transaction costs, the net realizable value of inventory, right-of-use assets, and income tax valuation allowances. Actual results could differ from these estimates.</span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>Concentrations of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Financial instruments which potentially subject the Company to credit risk consist principally of cash and accounts receivable. Primarily all cash is held in US financial institutions which, at times, exceed federally insured limits. The Company has not recognized any losses from credit risks on such accounts. The Company believes it is not exposed to significant credit risk on cash.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Additional credit risk is related to the Company’s concentration of receivables. As of June 30, 2024 and December 31, 2023, receivables were concentrated from one customer (which is a US. Government agency) representing 98% and 92% of total net receivables, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>One customer (which is a U.S. government agency) accounted for 94% and 95% for the three and six months ended June 30, 2024, respectively and 95% and 96% for the three and six months ended June 30, 2023, respectively of the recognized research and development revenue.</span></p>
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	9000000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	25000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	13000000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	13000000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2024Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	5400000	usd
CY2023Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	3700000	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1200000	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1200000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	9700000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	7700000	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2200000	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2300000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	2400000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	660000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	127000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	860000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	277000	usd
CY2024Q2	mdai	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Warrant Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiabilities	2024000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	-2374000	usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	660000	usd
CY2024Q2	mdai	Noncash Net Assets Assumed In Exchange For Common Stock NoncashNetAssetsAssumedInExchangeForCommonStock	-3034000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	200000	usd
CY2023Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	700000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1450000	usd
CY2024Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	7001000	usd
CY2024Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	8451000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1818000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	47000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-20000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	27000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-11000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	16000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	129000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-16000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	113000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	81000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	194000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4600000	usd
CY2024Q1	mdai	Change In Fair Value Of Notes Payable ChangeInFairValueOfNotesPayable	66000	usd
CY2024Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	4534000	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4600000	usd
CY2024Q2	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2300000	usd
CY2024Q2	mdai	Change In Fair Value Of Notes Payable ChangeInFairValueOfNotesPayable	-167000	usd
CY2024Q2	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7001000	usd
CY2024Q2	us-gaap	Revenues Revenues	7478000	usd
CY2023Q2	us-gaap	Revenues Revenues	4251000	usd
	us-gaap	Revenues Revenues	13804000	usd
	us-gaap	Revenues Revenues	9329000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2311000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1850000	usd
	mdai	Contract With Customer Liability Reductions ContractWithCustomerLiabilityReductions	2846000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1315000	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1439000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1910000	usd
CY2024Q2	mdai	Accrued Operating Expenses AccruedOperatingExpenses	655000	usd
CY2023Q4	mdai	Accrued Operating Expenses AccruedOperatingExpenses	1563000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	552000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	720000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	87000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	107000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2733000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4300000	usd
	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	2736000	usd
	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	175000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	8001000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	436000	usd
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	30000000	usd
CY2024Q1	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	12500000	usd
CY2024Q1	us-gaap	Cash Cash	4600000	usd
CY2024Q1	mdai	Discount Rate DiscountRate	0.08	pure
CY2024Q1	mdai	Percentage Of Prepaid Advance PercentageOfPrepaidAdvance	0.92	pure
CY2024Q1	mdai	Percentage Of Prepaid Advance At Annual Rate PercentageOfPrepaidAdvanceAtAnnualRate	0	pure
CY2024Q1	mdai	Percentage Of Increase In Convertible Notes PercentageOfIncreaseInConvertibleNotes	0.18	pure
	mdai	Installment Principal Amount InstallmentPrincipalAmount	750000	usd
	mdai	Installment Premium Rate InstallmentPremiumRate	0.07	pure
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2300000	usd
CY2024Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2024Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	300000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	600000	usd
CY2024Q2	us-gaap	Tenant Improvements TenantImprovements	300000	usd
CY2024Q2	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P12M
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	220000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	213000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	430000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	328000	usd
CY2024Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1771000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	483000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1771000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	483000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085	pure
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	182000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	198000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	387000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	392000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	64000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	133000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	169000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	192000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	246000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	331000	usd
	us-gaap	Lease Cost LeaseCost	556000	usd
	us-gaap	Lease Cost LeaseCost	584000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	36000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	78000	usd
CY2024Q2	mdai	Lease And Rental Expenses LeaseAndRentalExpenses	282000	usd
CY2023Q2	mdai	Lease And Rental Expenses LeaseAndRentalExpenses	331000	usd
	mdai	Lease And Rental Expenses LeaseAndRentalExpenses	634000	usd
	mdai	Lease And Rental Expenses LeaseAndRentalExpenses	584000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	463000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	691000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	850000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	871000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	149000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3024000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	437000	usd
CY2024Q2	mdai	Tenant Improvement Allowance TenantImprovementAllowance	-327000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2260000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	400000	usd
	mdai	Service Fee Costs ServiceFeeCosts	100000	usd
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	30000000	usd
CY2024Q1	mdai	Pre Paid Advance Disbursed Amount PrePaidAdvanceDisbursedAmount	4600000	usd
CY2024Q1	mdai	Prepaid Advance Net Discount Amount PrepaidAdvanceNetDiscountAmount	400000	usd
CY2024Q1	mdai	Prepaid Advance Net Discount Percentage PrepaidAdvanceNetDiscountPercentage	0.08	pure
CY2024Q2	us-gaap	Prepaid Interest PrepaidInterest	5000000	usd
CY2024Q2	mdai	Prepaid Advance Net Discount Amount PrepaidAdvanceNetDiscountAmount	400000	usd
CY2024Q2	mdai	Prepaid Advance Net Discount Percentage PrepaidAdvanceNetDiscountPercentage	0.08	pure
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	3000000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	8000000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue	12
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	600000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	58197	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.65
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	450000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.16
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	29098	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.45
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	9699	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.45
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	469400	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.97
CY2024Q2	us-gaap	Share Price SharePrice	1.76
CY2023Q2	us-gaap	Share Price SharePrice	0.44
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y7M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.66	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.72	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.043	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.035	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3598944	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.2
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8087000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	443437	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.76
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	58358	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.84
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	52700	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.59
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3931323	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.09
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1085000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3311097	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.9
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1066000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	86000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.024	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.015	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.013	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.013	pure
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12908034	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4760949	shares
CY2024Q1	us-gaap	Advances To Affiliate AdvancesToAffiliate	1000000	usd
CY2024Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2023Q2	mdai	Transaction Costs Incurred In Connection With Warrant Liabilities TransactionCostsIncurredInConnectionWithWarrantLiabilities		usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13210320	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17079328	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17598357	shares
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2024Q2	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	mdai	Change In Fair Values Of Notes Payable ChangeInFairValuesOfNotesPayable		usd
	mdai	Costs From Issuance Of Common Stock CostsFromIssuanceOfCommonStock		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	mdai	Unpaid Deferred Offering Costs UnpaidDeferredOfferingCosts		usd
	mdai	Broker Receivable For Stock Option Exercises BrokerReceivableForStockOptionExercises		usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001833498
	dei	Entity File Number EntityFileNumber	000-00000

Files In Submission

Name	View Source	Status
0001213900-24-067651-index-headers.html	Edgar Link	pending
0001213900-24-067651-index.html	Edgar Link	pending
0001213900-24-067651.txt	Edgar Link	pending
0001213900-24-067651-xbrl.zip	Edgar Link	pending
ea0211028-10q_spectral.htm	Edgar Link	pending
ea021102801ex31-1_spectral.htm	Edgar Link	pending
ea021102801ex31-2_spectral.htm	Edgar Link	pending
ea021102801ex32_spectral.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mdai-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mdai-20240630_cal.xml	Edgar Link	unprocessable
mdai-20240630_def.xml	Edgar Link	unprocessable
mdai-20240630_lab.xml	Edgar Link	unprocessable
mdai-20240630_pre.xml	Edgar Link	unprocessable
ea0211028-10q_spectral_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDAI
Spectral AI, Inc. Stock $mdai

2024 Q3 Form 10-Q Financial Statement

#000121390024067651 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDAI Spectral AI, Inc. Stock $mdai

2024 Q3 Form 10-Q Financial Statement

#000121390024067651 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDAI
Spectral AI, Inc. Stock $mdai